1. Home
  2. PPBT vs HTCR Comparison

PPBT vs HTCR Comparison

Compare PPBT & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Purple Biotech Ltd.

PPBT

Purple Biotech Ltd.

N/A

Current Price

$1.34

Market Cap

2.4M

Sector

Health Care

ML Signal

N/A

Logo Heartcore Enterprises Inc.

HTCR

Heartcore Enterprises Inc.

N/A

Current Price

$1.77

Market Cap

2.7M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
PPBT
HTCR
Founded
2010
2009
Country
Israel
Japan
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.4M
2.7M
IPO Year
2014
2022

Fundamental Metrics

Financial Performance
Metric
PPBT
HTCR
Price
$1.34
$1.77
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 41.9K
12.1K
Earning Date
11-13-2026
11-17-2026
Dividend Yield
N/A
★ 145.25%
EPS Growth
N/A
★ 414.29
EPS
★ N/A
N/A
Revenue
N/A
★ $30,407,229.00
Revenue This Year
N/A
$118.88
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 39.19
52 Week Low
$0.41
$0.15
52 Week High
$5.18
$3.97

Technical Indicators

Market Signals
Indicator
PPBT
HTCR
Relative Strength Index (RSI) 34.93 29.99
Support Level $1.16 N/A
Resistance Level $1.60 $2.16
Average True Range (ATR) 0.11 0.12
MACD -0.01 -0.02
Stochastic Oscillator 14.81 19.61

Price Performance

Historical Comparison
PPBT
HTCR

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.

About HTCR Heartcore Enterprises Inc.

HeartCore Enterprises Inc is a software development company providing solutions for digital transformation (DX). It develops, sells, and maintains CMS and CXM platforms using digital marketing technology, RPA, process mining solutions, myInvenio and Apromore, task mining solution CONTROLIO, and 3D-VR services including Matterport and VR360. The company also provides management consulting, education, services, and support to help customers succeed with the CXM Platform. It operates through two business units, the CX division for customer experience management and the DX division for digital transformation, which provides robotics process automation, process mining, and task mining. Its products include VR360, myInvenio, Apromore, and others, with maximum revenue from the United States.

Share on Social Networks: